Merkoša sitáhtat
APA-čujuhus (7. p.)
Caimi, P. F., Ai, W. Z., Alderuccio, J. P., Ardeshna, K. M., Hamadani, M., Hess, B., . . . Carlo-Stella, C. (2023). Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: Long-term efficacy and safety from the phase II LOTIS-2 study. Ferrata Storti Foundation.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Caimi, Paolo F., et al. Loncastuximab Tesirine in Relapsed/refractory Diffuse Large B-cell Lymphoma: Long-term Efficacy and Safety from the Phase II LOTIS-2 Study. Ferrata Storti Foundation, 2023.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Caimi, Paolo F., et al. Loncastuximab Tesirine in Relapsed/refractory Diffuse Large B-cell Lymphoma: Long-term Efficacy and Safety from the Phase II LOTIS-2 Study. Ferrata Storti Foundation, 2023.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.